Discover what's new.

Access the latest news, business developments, company updates, industry trends, events and more.

| By Kelley Gipson

CT Children’s wins grant to study COVID-19

The National Institutes of Health awarded a research grant to Connecticut Children’s Hospital to study risk factors for COVID-19 complications in children. Connecticut Children’s is...

| By Kelley Gipson

Hospital system to relocate 500 to Danbury

A hospital system will relocate 500 people from New York to Danbury in what is touted as the largest office-lease deal in the state for...

| By Kelley Gipson

BioCT and BIO request essential worker status

BioCT and the international BIO organization have write to authorities to request that certain biotechnology industry personnel be considered as essential workers slated to receive...

| By Kelley Gipson

CaroGen in pact with NIH to develop flu vaccine

Privately-held CaroGen Corporation has agreed with the National Institute of Allergy and Infectious Diseases, part of the NIH, to provide its AVIDIO-based recombinant influenza vaccine...

| By Kelley Gipson

Vanessa Research secures CE Marking for masks

Vanessa Research has secured the CE Marking, Module C Certificate, for its KLAREX brand KN95 masks. This certification attests to the conformity of the quality of...

| By Kelley Gipson

BI speaks of support for local communities

Yew Looi Liew, President of U.S. Human Pharma at Boehringer-Ingelheim, recently spoke at the Connecticut Bioscience Caucus about the company’s commitment to supporting local communities and...

| By Kelley Gipson

Dr. Nicole Wagner of LambdaVision recognized

WIA (Women in Aerospace) has recognized Dr. Nicole Wagner of LambdaVision for “exceptional leadership, creativity in expanding the boundaries of space-based research, and generous support...

| By Kelley Gipson

Azitra joins team to develop mosquito repellent

Growing Branford biotech Azitra is part of a team working to develop a long-lasting mosquito repellent for the U.S. military using the good bacteria that live...

| By Kelley Gipson

Sema4 and Merus in strategic support agreement

Sema4 reports it has entered into a strategic agreement with Merus, a Dutch company, to utilize Sema4’s advanced genomic testing to identify patients with tumors harboring...